Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

1.

Association of Factor V Secretion with Protein Kinase B Signaling in Platelets from Horses with Atypical Equine Thrombasthenia.

Norris JW, Pombo M, Shirley E, Blevins G, Tablin F.

J Vet Intern Med. 2015 Aug 19. doi: 10.1111/jvim.13595. [Epub ahead of print]

PMID:
26290457
2.

Automated external defibrillator prevalence among the municipal police agencies of New Jersey: how regional differences affect national data.

Pescatore RM, Hong R, Sexton RJ, Carroll GG, Curcio EE, Blevins G, Baumann BM.

Public Health. 2015 Jul 15. pii: S0033-3506(15)00245-0. doi: 10.1016/j.puhe.2015.06.009. [Epub ahead of print] No abstract available.

PMID:
26188851
3.

Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.

Cobzas D, Sun H, Walsh AJ, Lebel RM, Blevins G, Wilman AH.

J Magn Reson Imaging. 2015 May 18. doi: 10.1002/jmri.24951. [Epub ahead of print]

PMID:
25980643
4.

Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.

Radomski AD, Power C, Purdon SE, Emery DJ, Blevins G, Warren KG, Fujiwara E.

BMC Neurol. 2015 Apr 23;15:61. doi: 10.1186/s12883-015-0318-0.

5.

Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.

Datta S, Staewen TD, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA; MRI Analysis Center at Houston; CombiRx Investigators Group.

Mult Scler Relat Disord. 2015 Mar;4(2):124-36. doi: 10.1016/j.msard.2015.01.004. Epub 2015 Jan 17.

PMID:
25787188
6.

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.

Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators.

Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13.

7.

Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter.

Sun H, Walsh AJ, Lebel RM, Blevins G, Catz I, Lu JQ, Johnson ES, Emery DJ, Warren KG, Wilman AH.

Neuroimage. 2015 Jan 15;105:486-92. doi: 10.1016/j.neuroimage.2014.11.010. Epub 2014 Nov 8.

PMID:
25462797
8.

Associations between eating occasion characteristics and age, gender, presence of children and BMI among U.S. adults.

Reicks M, Degeneffe D, Rendahl A, Smith Edge M, Burns K, O'Meara B, Blevins G.

J Am Coll Nutr. 2014;33(4):315-27. doi: 10.1080/07315724.2014.887485. Epub 2014 Aug 20.

PMID:
25140673
9.

The regulation of reactive changes around multiple sclerosis lesions by phosphorylated signal transducer and activator of transcription.

Lu JQ, Power C, Blevins G, Giuliani F, Yong VW.

J Neuropathol Exp Neurol. 2013 Dec;72(12):1135-44. doi: 10.1097/NEN.0000000000000011.

PMID:
24226263
10.

Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.

Kang H, Metz LM, Traboulsee AL, Eliasziw M, Zhao GJ, Cheng Y, Zhao Y, Li DK; Minocycline in CIS Study Group.

Mult Scler. 2014 Apr;20(4):458-63. doi: 10.1177/1352458513501230. Epub 2013 Aug 22.

PMID:
23970502
11.

Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease.

Walsh AJ, Blevins G, Lebel RM, Seres P, Emery DJ, Wilman AH.

Radiology. 2014 Jan;270(1):186-96. doi: 10.1148/radiol.13130474. Epub 2013 Oct 28.

PMID:
23925273
12.

Randomized study combining interferon and glatiramer acetate in multiple sclerosis.

Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F, Salter AR, Gustafson T, Wolinsky JS; CombiRx Investigators.

Ann Neurol. 2013 Mar;73(3):327-40. doi: 10.1002/ana.23863. Epub 2013 Mar 11.

13.

MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary.

Selchen D, Bhan V, Blevins G, Devonshire V, Duquette P, Grand'Maison F, Kremenchutzky M, Lapierre Y, Li D, von Riedemann SJ, Freedman M.

Neurology. 2012 Dec 4;79(23 Suppl 2):S1-15. doi: 10.1212/WNL.0b013e318277d144.

PMID:
23212280
14.

Multiple sclerosis: validation of MR imaging for quantification and detection of iron.

Walsh AJ, Lebel RM, Eissa A, Blevins G, Catz I, Lu JQ, Resch L, Johnson ES, Emery DJ, Warren KG, Wilman AH.

Radiology. 2013 May;267(2):531-42. doi: 10.1148/radiol.12120863. Epub 2013 Jan 7.

PMID:
23297322
15.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators.

N Engl J Med. 2012 Sep 20;367(12):1087-97. Erratum in: N Engl J Med. 2012 Oct 25;367(17):1673.

16.

Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering.

Walsh AJ, Eissa A, Blevins G, Wilman AH.

J Magn Reson Imaging. 2012 Dec;36(6):1460-9. doi: 10.1002/jmri.23768. Epub 2012 Aug 3.

PMID:
22865696
17.

Intrathecal effects of daclizumab treatment of multiple sclerosis.

Bielekova B, Richert N, Herman ML, Ohayon J, Waldmann TA, McFarland H, Martin R, Blevins G.

Neurology. 2011 Nov 22;77(21):1877-86. doi: 10.1212/WNL.0b013e318239f7ef. Epub 2011 Nov 9.

18.

Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis.

Lebel RM, Eissa A, Seres P, Blevins G, Wilman AH.

Mult Scler. 2012 Apr;18(4):433-41. doi: 10.1177/1352458511428464. Epub 2011 Oct 27.

PMID:
22032862
19.

Efficacy and safety of subcutaneous interferon β-1a in relapsing-remitting multiple sclerosis: further outcomes from the IMPROVE study.

De Stefano N, Sormani MP, Stubinski B, Blevins G, Drulovic JS, Issard D, Shotekov P, Gasperini C.

J Neurol Sci. 2012 Jan 15;312(1-2):97-101. doi: 10.1016/j.jns.2011.08.013. Epub 2011 Aug 31.

PMID:
21880336
20.

Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis.

De Stefano N, Curtin F, Stubinski B, Blevins G, Drulovic J, Issard D, Shotekov P, Gasperini C; IMPROVE Study Investigators.

Mult Scler. 2010 Jul;16(7):888-92. doi: 10.1177/1352458510362442. Epub 2010 Mar 3.

PMID:
20200197
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk